Table 3.
Records of Boswellia serrata | Year of Publication | Study Design | Blind | Ref. | |
---|---|---|---|---|---|
1 | Dietary support with Boswellia resin in canine inflammatory joint and spinal disease | 2004 | Prospective multicentre Type III |
No | [34] |
2 | A medicinal herb-based natural health product improves the condition of a canine natural osteoarthritis model: a randomized placebo-controlled trial | 2014 | Type I | Double-blind | [68] |
3 | Effect of a commercially available fish-based dog food enriched with nutraceuticals on hip and elbow dysplasia in growing Labrador retrievers | 2018 | Type I | Yes | [52] |
4 | Effects of a nutritional supplement in dogs affected by osteoarthritis | 2019 | Type I | Double-blind | [26] |
5 | Placebo-controlled pilot study of the effects of an eggshell membrane-based supplement on mobility and serum biomarkers in dogs with osteoarthritis | 2019 | Type I | Double-blind | [69] |
6 | Effects on Pain and Mobility of a New Diet Supplement in Dogs with Osteoarthritis: A Pilot Study | 2019 | Type III | No | [54] |
7 | Clinical efficacy of Curcuvet and Boswellic acid combined with conventional nutraceutical product: An aid to canine osteoarthritis | 2021 | Type II | Double-blind | [70] |
8 | Preliminary results on the efficacy of a dietary supplement combined with physiotherapy in dogs with osteoarthritis on biomarkers of oxidative stress and inflammation | 2021 | Type I | Double-blind | [71] |
9 | Long-term effects of a diet supplement containing Cannabis sativa oil and Boswellia serrata in dogs with osteoarthritis following physiotherapy treatments: a randomised, placebo-controlled and double-blind clinical trial | 2022 | Type I | Double-blind | [72] |
10 | A pilot study examining a proprietary herbal blend for the treatment of canine osteoarthritis pain | 2022 | Type I | Double-blind | [73] |